SYM-2081
SYM-2081 is a synthetic compound that acts as a selective agonist at the kainate receptor, a type of ionotropic glutamate receptor in the brain. It is used primarily in scientific research to study the function of kainate receptors.
Chemistry[edit]
SYM-2081 is a derivative of willardiine, a naturally occurring compound found in the seeds of the plant Acacia willardiana. It is synthesized by substituting the 5-position of the willardiine molecule with a sulfonamide group, which increases its potency and selectivity for the kainate receptor.
Pharmacology[edit]
As a kainate receptor agonist, SYM-2081 binds to and activates the kainate receptor, mimicking the effect of the neurotransmitter glutamate. This allows it to be used in research to study the role of kainate receptors in various neurological processes, including neurotransmission, synaptic plasticity, and neuronal excitability.
Research Use[edit]
SYM-2081 has been used in a variety of research contexts. For example, it has been used to study the role of kainate receptors in epilepsy, as overactivation of these receptors can lead to excessive neuronal firing and seizures. It has also been used to investigate the role of kainate receptors in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as these receptors have been implicated in the death of neurons in these conditions.
Safety[edit]
As a research chemical, SYM-2081 is not intended for human consumption. Its safety profile in humans is unknown.
See Also[edit]
SYM-2081 gallery[edit]
-
SYM2081
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian